References

1. [1].
   STARRENBURG ME, BEL IMAMM, LOPEZ JF, et al. Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis[J]. J Allergy Clin Immunol, 2024, 154(5): 1333-1338.
2. [2].
   NUTTEN S. Atopic dermatitis: global epidemiology and risk factors[J]. Ann Nutr Metab, 2015, 4(1): 8-16.
3. [3].
   灵枢经[M].刘更生,校注.北京:中国中医药出版社, 2006.
4. [4].
   O'NEILL CA, MONTELEONE G, MCLAUGHLIN JT, et al. The gut-skin axis in health and disease: a paradigm with therapeutic implications[J]. Bioessays, 2016, 38 (11): 1167-1176.
5. [5].
   王冰.黄帝内经素问[M].北京:人民卫生出版社, 1963.
6. [6].
   李际强,王河宝.升清降浊法的理论基础及临床意义[J].江西中医学院学报, 2007, 19(2): 13-14.
7. [7].
   黄元御.四圣心源[M].徐静,宋白杨,校注.北京:中国医药科技出版社, 2020: 44.
8. [8].
   李中梓.本草通玄[M].付先军,周扬,范磊,等,校注.北京:中国中医药出版社, 2015: 4.
9. [9].
   中华中医药学会皮肤科专业委员会.特应性皮炎中医诊疗方案专家共识[J].中国中西医结合皮肤性病学杂志, 2013, 12(1): 60-61.
10. [10].
    李丹阳,吕添,于莹,等.论特应性皮炎核心病机与辨治思路[J].世界中医药, 2024, 19(2): 200-204.
11. [11].
    李杲.脾胃论[M].北京:中国中医药出版社, 2019.
12. [12].
    巢元方.诸病源候论:五十卷[M].影印本.北京:人民卫生出版社, 1955: 184.
13. [13].
    PARK DH, KIM JW, PARK HJ, et al. Comparative analysis of the icrobiome across the gut-skin axis in atopic dermatitis[J]. Int J Mol Sci, 2021, 22(8): 4228.
14. [14].
    SALEM I, RAMSER A, ISHAM N, et al. The gut microbiome as a major regulator of the gut-skin axis[J]. Front Microbiol, 2018, (9): 1459.
15. [15].
    SUN S, LUO LJ, LIANG WH, et al. Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade[J]. Proc Natl Acad Sci U S A, 2020, 117(44): 27509-27515.
16. [16].
    RAVINDRAN R, LOEBBERMANN J, NAKAYA HI, et al. The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation[J]. Nature, 2016, 531(7595): 523-527.
17. [17].
    AHN SH, YOON W, LEE SY, et al. Effects of Lactobacillus pentosus in children with allergen-sen-sitized atopic dermatitis[J]. J Korean Med Sci, 2020, 35(18): e128.
18. [18].
    GHOSH S, WHITLEY CS, HARIBABU B, et al. Regulation of intestinal barrier function by microbial metabolites[J]. Cell Mol Gastroenterol Hepatol, 2021, 11(5):1463-1482.
19. [19].
    方勇,万芮含,黄洁,等.基于“脾藏营舍意”探讨肠道微生态与老年肌少症相关认知功能障碍的关系[J].中国中医基础医学杂志, 2025, 31(4): 587-591.
20. [20].
    刘雷蕾,孟静岩.从中医基础理论角度认识肠道微生态[J].北京中医药大学学报, 2016, 39(9): 724-727.
21. [21].
    袁久术,周明阳,冷玉琳,等.基于肠道菌群失调探讨“升清降浊”理论在糖尿病周围神经病变中的作用[J].世界科学技术—中医药现代化, 2023, 25(4):1494-1501.
22. [22].
    张小娟,蒋珍秀,董娜.基于肠道微生态及“肠-肾轴”理论探讨慢性,肾脏病从脾论治机理[J].中国中医药信息杂志, 2020, 27(6): 14-17.
23. [23].
    郑昊龙,陈丝,宋囡,等.脾虚模型大鼠肠道菌群分布及时效性研究[J].中医杂志, 2020, 61(14): 1262-1267.
24. [24].
    裴悦,肖水明,莫秀梅,等.培土清心方对特应性皮炎儿童肠道菌群的影[J].中国皮肤性病学杂志, 2020, 34(6): 688-691.
25. [25].
    王奕夫,邱宝山,李锦锦,等.健脾化湿法对特应性皮炎患者免疫调节作用的研究[J].世界中医药, 2020, 15(20): 3109-3112.
26. [26].
    SINHA S, LIN G, FERENCZI K. The skin microbiome and the gut-skin axis[J]. Clin Dermatol, 2021, 39 (5): 829-839.
27. [27].
    TROMPETTE A, PERNOT J, PERDIJK O, et al. Gutderived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation[J]. Mucosal Immunol, 2022, 15(5): 908-926.
28. [28].
    THYE AYK, BAH YR, LAW JWF, et al. Gut-skin axis:unravelling the connection between the gut microbiome and psoriasis[J]. Biomedicines, 2022, 10(5): 1037.
29. [29].
    张仲景.伤寒论[M].杨金萍,罗良,何勇,点校.北京:中国中医药出版社, 2006: 7.
30. [30].
    何治宏,张丰川,杨顶权,等.基于“营卫气化”理论探讨修复皮肤屏障在特应性皮炎中的运用[J].中国医药导报, 2024, 21(27): 146-149.
31. [31].
    刘聪,徐爽,周晖文,等.特应性皮炎皮肤屏障受损与“风性开泄”义理钩玄[J].中华中医药杂志, 2021, 36(6): 3670-3672.
32. [32].
    中国中药协会皮肤病药物研究专业委员会,中国老年保健医学研究会皮肤科分会,中国中西医结合学会皮肤性病专委会环境与职业性皮肤病学组.特应性皮炎中西医结合诊疗临床路径专家共识[J].中国中西医结合皮肤性病学杂志, 2024, 23(5): 465-470.
33. [33].
    郑丰杰.从方证相应与方-证要素对应谈经方临床应用[J].北京中医药大学学报, 2015, 38(10): 653-657.
34. [34].
    孙思邈.备急千金要方[M].北京:中国中医药出版社, 1955: 273.
35. [35].
    安婉丽,李雪丽,孔冉,等.中医药治疗肠道菌群失调症的方剂用药规律分析[J].中国实验方剂学杂志, 2018, 24(12): 210-215.
36. [36].
    张苍.赵炳南辨治皮肤湿病理法探究[J].北京中医药, 2019, 38(11): 1059-1062.
37. [37].
    董芮,张益生,蔡洵,等.从伏湿辨治特应性皮炎思路探讨[J].河北中医, 2024, 46(5): 849.
38. [38].
    郭昕炜,李冠汝,李萍,等.加减除湿胃苓汤治疗脾虚湿蕴型特应性皮炎的临床疗效观察[J].中华中医药杂志, 2020, 35(1): 458-460.
39. [39].
    唐毅,周瑶,陈敏,等.基于LC-MS的除湿胃苓汤加减治疗脾虚湿蕴型慢性湿疹的血清代谢组学研究[J].中国现代药物应用, 2023, 17(19): 1-6.
40. [40].
    张玉鑫,郑丰杰.麻黄连轺赤小豆汤治疗皮肤病应用规律探讨[J].长春中医药大学学报, 2020, 36 (5): 1080-1083.
41. [41].
    YUAN HM, PIAN X, CUI J, et al. Exploring the effect of Mahuang Lianqiao Chixiaodou decoction on NLRP3 cell pyroptosis in an atopic dermatitis-like mouse mode[J]. J Tradit Chin Med Sci, 2023, 10(4): 461-469.
42. [42].
    YUAN HM, TANG Y, ZHANG SJ, et al. NLRP3 neuroinflammatory intervention of Mahuang-Lianqiao-Chixiaodou decoction for mental disorders in atopic dermatitis mice[J]. J Ethnopharmacol, 2024, 319 ( Pt 2 ):117263.
43. [43].
    刘渡舟.经方临证指南[M].天津:天津科学技术出版社, 1993.
44. [44].
    周祎青,郑裕华,陈颂,等.连翘对岭南湿热模型小鼠的作用及其肠道菌群变化的研究[J].中药新药与临床药理, 2019, 30(6): 678-685.
45. [45].
    KIM HB, GO EJ, BAEK JS. Effect of hot-melt extruded Morus alba leaves on intestinal microflora and epithelial cells[J]Heliyon, 2023, 10(1): e23954.
46. [46].
    蒋沁璋.赤小豆多酚的组成、生物可及性及其与肠道菌群相互作用的研究[D].海口:海南大学, 2023.